Extracellular Release of Citrullinated Vimentin Directly Acts on Osteoclasts to Promote Bone Resorption in a Mouse Model of Periodontitis
Authors:
- Satoru ShindoSSSatoru Shindo
- Roodelyne PierrelusRPRoodelyne Pierrelus
- Atsushi IkedaAIAtsushi Ikeda
- Shin NakamuraSNShin Nakamura
- Alireza HeidariAHAlireza Heidari
- Maria Rita PastoreMPMaria Rita Pastore
- Elizabeth LeonELElizabeth Leon
- Sunniva RuizSRSunniva Ruiz
- Harsh ChhedaHCHarsh Chheda
- Rhea KhatiwalaRKRhea Khatiwala
- Tomoki KumagaiTKTomoki Kumagai
- George TolsonGTGeorge Tolson
Open Access
Abstract
Elevated osteoclast (OC)-mediated bone resorption, a common pathological feature between periodontitis and rheumatoid arthritis (RA), implicates a possible mutually shared pathogenesis. The autoantibody to citrullinated vimentin (CV), a representative biomarker of RA, is reported to promote osteoclastogenesis (OC-genesis). However, its effect on OC-genesis in the context of periodontitis remains to be elucidated. In an in vitro experiment, the addition of exogenous CV upregulated the development of Tartrate-resistant acid phosphatase (TRAP)-positive multinuclear OCs from mouse bone marrow cells and increased the formation of resorption pits. However, Cl-amidine, an irreversible pan-peptidyl arginine deiminase (PAD) inhibitor, suppressed the production and secretion of CV from RANKL-stimulated OC precursors, suggesting that the citrullination of vimentin occurs in OC precursors. On the other hand, the anti-vimentin neutralizing antibody suppressed in vitro Receptor activator of nuclear factor kappa-Β ligand (RANKL)-induced OC-genesis. The CV-induced upregulation of OC-genesis was abrogated by the Protein kinase C (PKC)-δ inhibitor Rottlerin, accompanied by the downmodulation of OC-genesis-related genes, including Osteoclast stimulatory transmembrane protein (OC-STAMP), TRAP and Matrix Metallopeptidase 9 (MMP9) as well as extracellular signal-regulated kinase (ERK) mitogen-activated protein (MAP)-kinase phosphorylation. Elevated levels of soluble CV and vimentin-bearing mononuclear cells were found in the bone resorption lesions of periodontitis induced in mice in the absence of an anti-CV antibody. Finally, local injection of anti-vimentin neutralizing antibody suppressed the periodontal bone loss induced in mice. Collectively, these results indicated that the extracellular release of CV promoted OC-genesis and bone resorption in periodontitis.Keywords
Funding Information
- NIDCR grants (DE025255, DE027851, DE028715, DE029709)
This publication has 76 references indexed in Scilit:
- Quantitative Proteomic Analysis of Gingival Crevicular Fluid in Different Periodontal ConditionsPLOS ONE, 2013
- Loss of Protein Kinase C-δ Protects against LPS-Induced Osteolysis Owing to an Intrinsic Defect in Osteoclastic Bone ResorptionPLOS ONE, 2013
- Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentinJournal of Clinical Investigation, 2012
- Review of osteoimmunology and the host response in endodontic and periodontal lesionsJournal of Oral Microbiology, 2011
- Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritisArchives of Medical Science, 2011
- Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorptionBMC Musculoskeletal Disorders, 2010
- Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factorArthritis Research & Therapy, 2010
- Natural killer cells trigger osteoclastogenesis and bone destruction in arthritisProceedings of the National Academy of Sciences, 2009
- B and T Lymphocytes Are the Primary Sources of RANKL in the Bone Resorptive Lesion of Periodontal DiseaseThe American Journal of Pathology, 2006
- Osteoclast differentiation and activationNature, 2003